Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364774
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-03-26
Brief Title:
ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
Sponsor:
Childrens Hospital of Philadelphia
Organization:
Childrens Hospital of Philadelphia
Organization Data
Organization:
Childrens Hospital of Philadelphia
Class:
OTHER
Study ID:
22-020309
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Hospital of Philadelphia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None